Karen Moor (@karenmoor2) 's Twitter Profile
Karen Moor

@karenmoor2

Pulmonologist in training with a special interest in interstitial lung disease. Post-doctoral researcher: innovations in ILD @ Erasmus MC

ID: 1433089462746107910

calendar_today01-09-2021 15:30:29

35 Tweet

139 Followers

87 Following

Respirology (@respirologyapsr) 's Twitter Profile Photo

Don't miss the latest 'Recommendations from The Medical Education Editor' in #Respirologyto stay up to date with continued professional development - free to read at ow.ly/biGs50KBJ6m Mark Lavercombe ILD.ErasmusMC Karen Moor

Don't miss the latest 'Recommendations from The Medical Education Editor' in #Respirologyto stay up to date with continued professional development - free to read at ow.ly/biGs50KBJ6m <a href="/LavercombeMark/">Mark Lavercombe</a> <a href="/ILD_ErasmusMC/">ILD.ErasmusMC</a> <a href="/KarenMoor2/">Karen Moor</a>
Karen Moor (@karenmoor2) 's Twitter Profile Photo

Now online: an overview of experiences, challenges, and future perspectives on home monitoring in interstitial lung diseases thelancet.com/journals/lanre…

ERS Early-Career Members (@earlycareerers) 's Twitter Profile Photo

Dear early-career members, the ERS Guidelines Working Group set up a survey to improve the accessibility of ERS Clinical Practice Guidelines. 🔽🔽🔽 Completion of this survey takes about 10 minutes. surveymonkey.com/r/DX376DC Please complete it before 6th December. THANK YOU! 🙏

Karen Moor (@karenmoor2) 's Twitter Profile Photo

Mindfulness cognitive behavioral therapy improves fatigue, anxiety, depressive symptoms, and health status in patients with sarcoidosis-associated fatigue. Results of the multicenter TIRED RCT now online The Lancet Respiratory Medicine sciencedirect.com/science/articl…

The Lancet Respiratory Medicine (@lancetrespirmed) 's Twitter Profile Photo

The Jan 2023 issue of The Lancet Respiratory Medicine is here! As we kick of our 10th anniversary year🥳we have lots of great content for you: Series on #digitalhealth in #ILD, studies on #influenza, #ILD, #asthma, #IPF, & #NSCLC, & much more! Read it here bit.ly/3jkg5CS

The Jan 2023 issue of <a href="/LancetRespirMed/">The Lancet Respiratory Medicine</a> is here! 

As we kick of our 10th anniversary year🥳we have lots of great content for you: Series on #digitalhealth in #ILD, studies on #influenza, #ILD, #asthma, #IPF, &amp; #NSCLC, &amp; much more!

Read it here bit.ly/3jkg5CS
patientMpower (@patientmpower) 's Twitter Profile Photo

A super new review article from Gizal Nakshbandi and colleagues at Erasmus MC on new internet based technologies for #ILD patient care "in the near future innovative technologies will further enhance individually targeted treatment for patients with ILD" journals.lww.com/co-pulmonaryme…

Thomas GILLE (MD, PhD) 🫁 (@thomasgille_md) 's Twitter Profile Photo

Drop a cool photo of you doing your job (📸: a friendly waiter) OK, it may look like I’m cheating, but we were actually planning the 2022 #ERSCongress in Barcelona with ERS Early-Career Members. Looking forward to beginning the 2023 edition in September in Milan!

Drop a cool photo of you doing your job 
(📸: a friendly waiter)

OK, it may look like I’m cheating, but we were actually planning the 2022 #ERSCongress in Barcelona with <a href="/EarlyCareerERS/">ERS Early-Career Members</a>. 
Looking forward to beginning the 2023 edition in September in Milan!
ERS Early-Career Members (@earlycareerers) 's Twitter Profile Photo

You can now access the Early View of ERS international congress 2023: highlights from the Interstitial Lung Diseases Assembly ERS publications prepared by ERS Assembly 12 - ILD ECMs led by Karen Moor openres.ersjournals.com/content/early/…

You can now access the Early View of ERS international congress 2023: highlights from the Interstitial Lung Diseases Assembly <a href="/ERSpublications/">ERS publications</a> prepared by <a href="/ers_ild/">ERS Assembly 12 - ILD</a> ECMs led by <a href="/KarenMoor2/">Karen Moor</a> 
openres.ersjournals.com/content/early/…
ERS (@eurorespsoc) 's Twitter Profile Photo

ERS members can now nominate a member under the age of 40 to receive the prestigious ERS Early Career Member Award in 2024. Find out more and nominate by 8 Feb! ow.ly/4aAz50QhWrT

ERS members can now nominate a member under the age of 40 to receive the prestigious ERS Early Career Member Award in 2024.

Find out more and nominate by 8 Feb! 

ow.ly/4aAz50QhWrT
ERS publications (@erspublications) 's Twitter Profile Photo

European Respiratory Journal: Based on changes in scores on the Living with Pulmonary Fibrosis (L-PF) questionnaire, nintedanib reduced worsening of dyspnoea, fatigue and cough over 52 weeks in patients with progressive pulmonary fibrosis bit.ly/3t7k4Im

European Respiratory Journal: Based on changes in scores on the Living with Pulmonary Fibrosis (L-PF) questionnaire, nintedanib reduced worsening of dyspnoea, fatigue and cough over 52 weeks in patients with progressive pulmonary fibrosis bit.ly/3t7k4Im
Laura Fabbri (@istamina) 's Twitter Profile Photo

If you are an early career member and want to be more involved with the Society, do not miss this appointment tomorrow! Stop by to say hello #ECM #ERScongress2024

If you are an early career member and want to be more involved with the Society, do not miss this appointment tomorrow! Stop by to say hello #ECM #ERScongress2024
Laura Fabbri (@istamina) 's Twitter Profile Photo

I hope you enjoyed meeting us! Please fill out the form above and keep your competencies list up to date on Myers' profile.

I hope you enjoyed meeting us! Please fill out the form above and keep your competencies list up to date on Myers' profile.
Karen Moor (@karenmoor2) 's Twitter Profile Photo

Great pro-con debate between ILD IPF Doc: Nazia Chaudhuri and George Margaritopoulos answering the question: Should advanced age and comorbidities prevent you from initiating antifibrotic therapy? If you're not present, watch it on your way back home! #ERSCongress2024 Katerina Antoniou

Great pro-con debate between <a href="/ILDIPFDoc_NI/">ILD IPF Doc: Nazia Chaudhuri</a> and George Margaritopoulos answering the question: Should advanced age and comorbidities prevent you from initiating antifibrotic therapy?  If you're not present, watch it on your way back home! #ERSCongress2024 <a href="/Katerin16265046/">Katerina Antoniou</a>
ERS Assembly 12 - ILD (@ers_ild) 's Twitter Profile Photo

Thanks for a fantastic ERS congress. We've had so many inspiring ILD sessions and were very happy to meet old friends and new (young) colleagues! Safe trip back home and see you in Amsterdam next year. #ERSCongress2024 #Assembly12 Michael Kreuter Katerina Antoniou Karen Moor

Thanks for a fantastic ERS congress. We've had so many inspiring ILD sessions and were very happy to meet old friends and new (young) colleagues! Safe trip back home and see you in Amsterdam next year. #ERSCongress2024 #Assembly12 <a href="/michael_kreuter/">Michael Kreuter</a> <a href="/Katerin16265046/">Katerina Antoniou</a> 
<a href="/KarenMoor2/">Karen Moor</a>
ERS Assembly 12 - ILD (@ers_ild) 's Twitter Profile Photo

🚨 Only 2 weeks left to apply for the ECM Mentoring Programme! 🚨 If you applied before Jan 15, please resubmit your application to ensure it's received. Don't miss this opportunity—apply now!

Malik Althobiani | مالك (@drmal1k) 's Twitter Profile Photo

سعدت بالمشاركة🇸🇦 في كتابة هذه الورقة مع نخبة من الباحثين المتميزين من هولندا، ألمانيا، بريطانيا، وإيطاليا، والمنشور في ERJ Open Research. Karen Moor Laura Fabbri Our latest article has been published in ERJ Open Research! It was a pleasure to work with Dr Laura, Karen, Prof.

سعدت بالمشاركة🇸🇦 في كتابة هذه الورقة مع نخبة من الباحثين المتميزين من هولندا، ألمانيا، بريطانيا، وإيطاليا، والمنشور في ERJ Open Research.
<a href="/KarenMoor2/">Karen Moor</a> <a href="/Istamina/">Laura Fabbri</a> 

Our latest article has been published in ERJ Open Research! It was a pleasure to work with Dr Laura, Karen, Prof.